Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$8.72
-3.00%
Mkt Cap $449.19M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$24.50
Range $19.00 – $30.00
Implied Upside
+181.0%
Consensus $24.50 vs current $8.72
NASDAQ·Healthcare·Biotechnology
$8.72
-3.00%
Mkt Cap $449.19M
No recent rating data.
Price Target (15 analysts)
$24.50
Range $19.00 – $30.00
+181.0%
Consensus $24.50 vs current $8.72